Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

CDT vs AAL: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

AAL Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 9–1 Matrix Metrics)

AAL Overall Winner 6-Pillar Tally: CDT 0 – 6 AAL Matrix Metrics: CDT 1 – 9 AAL

As of Nov 20, 2026, American Airlines Group Inc. (AAL) is the stronger overall head-to-head candidate over CDT Equity Inc. (CDT) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CDT carries a Unified Composite Score of 31.6/100 (SELL) at $0.23 (N/M Forward P/E, 0.0% operating margin), whereas AAL carries 44.7/100 (HOLD) at $11.90 (10.9x Forward P/E, 1.8% operating margin).

  • Technical & Structure Timing Caution: CDT is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 44.1); meanwhile AAL is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 37.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CDT vs AAL
CDT NASDAQ
CDT Equity Inc. Common Stock
Pharmaceutical Preparations
$0.23
-13.89% 1D
Market Cap $507,528
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol -17.75β · 10175% Vol
Unified Composite Score
31.6 / 100 SELL
Tech 15.0 Fund 37.0 Flow 50.0 Mom 54.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -58.9%), weak momentum, RSI 44
RSI-14: 44.1 · SMA20: $0.31 · SMA50: $0.40
AAL NASDAQ Head-to-Head Winner
American Airlines Group Inc.
Air Transportation, Scheduled
$11.90
-6.45% 1D
Market Cap $8.4B
TTM Revenue $61.0B
Forward P/E 10.9x
Beta / 30D Vol 1.82β · 55% Vol
Unified Composite Score
44.7 / 100 HOLD
Tech 25.0 Fund 45.0 Flow 58.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -1.5%), weak momentum, RSI 38
RSI-14: 37.8 · SMA20: $13.05 · SMA50: $12.92

6-Pillar Scorecard Institutional Category Breakdown (CDT 0 – 6 AAL)

Columns: Metric · CDT · AAL
1. Valuation Multiples AAL
Forward P/E N/M 10.9x
Trailing P/E N/M 11.2x
PEG Ratio N/M 0.21x
EV / Revenue N/M 0.7x
2. Growth & Scale AAL
Revenue Growth (YoY) +0.0% +19.3%
Earnings Growth (YoY) +0.0% -88.2%
TTM Revenue (USD) N/A $61.0B
Market Cap $507,528 $8.4B
3. Profitability & Quality AAL
Gross Margin N/A 20.8%
Operating Margin 0.0% 1.8%
Net Profit Margin 0.0% -0.8%
Return on Equity (ROE) -69.7% 0.0%
4. Balance Sheet & Cash Flow AAL
Cash Generation (TTM) N/A -$91M
Cash Flow Margin N/A -0.1%
Net Cash / Leverage $435,000 Net Debt (0.01x D/E) $36.1B Net Debt
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning AAL
Options Structure Phase BREAKDOWN BREAKDOWN
Current IV / %ile N/A (N/A) 63.2% (22nd %ile)
Put/Call OI Skew N/A 1.70x (Put-Skewed)
OBV Trend / Tech Phase NEUTRAL · Markdown DISTRIBUTION · Markdown
6. R&D & Supply-Chain Moat AAL
OpEx & R&D Intensity N/A 19.0% of Rev ($11.6B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Biotechnology Operator Airlines Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CDT (1) vs AAL (9)
Institutional Metric CDT AAL Criterion Row Edge
Market Capitalization
Scale
$507,528 $8.4B Larger Scale AAL
Trailing P/E Ratio
Valuation
N/M 11.2x Lower Multiple AAL
Forward P/E Ratio
Valuation
N/M 10.9x Lower Multiple AAL
Revenue Growth (YoY)
Growth
+0.0% +19.3% Higher Growth AAL
Operating Margin (TTM)
Profitability
0.0% 1.8% Higher Margin AAL
Net Profit Margin
Profitability
0.0% -0.8% Higher Margin CDT
Return on Equity (ROE)
Capital Efficiency
-69.7% 0.0% Higher ROE AAL
52-Week Range Position
Momentum
2% ($0–$11) 21% ($10–$19) Stronger Trend AAL
Beta / 30D Volatility
Risk Regime
-17.75β · 10175% Vol 1.82β · 55% Vol Lower Realized Risk AAL
Unified Institutional Score
Composite Signal
31.6 / 100 (SELL) 44.7 / 100 (HOLD) Higher Composite AAL
Trailing 12M Revenue (USD)
Operating Scale
N/A $61.0B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A 20.8% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev 0.21x PEG · 0.7x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A ($435,000 Net Debt (0.01x D/E)) -$91M ($36.1B Net Debt) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CDT +82.35 pp
CDT: +76.79% · AAL: -5.56%
3M Horizon AAL +78.07 pp
CDT: -90.76% · AAL: -12.69%
6M Horizon AAL +64.02 pp
CDT: -78.1% · AAL: -14.08%
1Y Horizon AAL +83.29 pp
CDT: -86.78% · AAL: -3.49%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CDT vs AAL. Trailing 12-month operating profitability (CDT 0.0% vs AAL 1.8%) and valuation multiples (CDT N/M vs AAL 10.9x Forward P/E) are benchmarked directly in Pillar 4 below.

CDT ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. Margin0.0%
ROE / Fwd P/E-69.7% · N/M
AAL ADR TTM Benchmark FX-Normalized USD
TTM Revenue$61.0B
Gross Margin20.8%
Op. Margin1.8%
ROE / Fwd P/E0.0% · 10.9x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CDT BREAKDOWN
163d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CDT Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
AAL BREAKDOWN
105d in phase · OBV DISTRIBUTION
Current IV 63.2%
IV Percentile 22nd %ile
Put/Call OI Skew 1.70x (Put-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact AAL Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $13.24 · IV 47.8%

AAL Simulated 5-Day Option Payoffs vs. Owning 100 Shares ($1,324)

Compare $1,324 in 100-share capital outlay against risk-defined 5-day vertical spreads, put-wall income, and 3-leg structures at 47.8% ATM IV.

5-DAY BULLISH SWING Liq A

Dec 18 $13 / $15 Bull Call Spread

Buy 1x $13C · Sell 1x $15C · 31d

Net Entry $67 Debit
T+5d @ +5% Move +$26 (+39%)
Max Risk / Buffer $67 Capped
5d Edge & Liquidity 0.9x R:R · Liq A
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq A

Dec 18 $12 / $11 Bull Put Spread

Sell 4x $12P · Buy 4x $11P · 31d

Net Entry $64 Credit
Max Credit / Yield +$64 (+19.0% RoM)
Max Risk / Buffer -10.6% Cushion ($336 Mgn)
5d Edge & Liquidity 77% PoP · Liq A
Simulate 5-Day Payoff →
5-DAY DOWNSIDE SPREAD Liq A

Dec 18 $14 / $12 Bear Put Spread

Buy 1x $14P · Sell 1x $12P · 31d

Net Entry $95 Debit
T+5d @ -5% Drop +$26 (+28%)
Max Risk / Buffer $95 Capped
5d Edge & Liquidity 0.8x R:R · Liq A
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CDT Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $507,528 market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
AAL Moat Profile Cyclical / Execution-Driven Positioning
Airlines Operator
Competes within the Airlines value chain with $8.4B market capitalization and 1.8% operating margin.
OpEx & R&D Reinvestment 19.0% of Rev ($11.6B)
90D Engineering Disclosures 0 Published

Investor FAQ CDT vs AAL Key Questions & Quantitative Answers

As of Nov 20, 2026, American Airlines Group Inc. (AAL) is the stronger overall head-to-head candidate over CDT Equity Inc. (CDT) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CDT carries a Unified Composite Score of 31.6/100 (SELL) at $0.23 (N/M Forward P/E, 0.0% operating margin), whereas AAL carries 44.7/100 (HOLD) at $11.90 (10.9x Forward P/E, 1.8% operating margin). Technical & Structure Timing Caution: CDT is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 44.1); meanwhile AAL is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 37.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

AAL leads the Growth & Scale pillar: CDT posts +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin), compared with AAL at +19.3% YoY revenue growth and -88.2% YoY earnings growth on $61.0B TTM revenue (20.8% gross margin, 1.8% operating margin). On trailing 12-month operating scale, CDT generates N/A in USD-normalized revenue versus $61.0B for AAL. In operating R&D and SG&A reinvestment, CDT deploys N/A (0 90-day corporate R&D disclosures) versus 19.0% of Rev ($11.6B) (0 disclosures) for AAL.

AAL screens cheaper on headline valuation multiples. CDT trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas AAL trades at 10.9x Forward P/E, 11.2x Trailing P/E, 0.21x PEG, and 0.7x EV/Revenue (-0.1% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CDT (-69.7% ROE) versus AAL (0.0% ROE) capital efficiency.

In options market volatility and institutional positioning, CDT carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (-17.75β · 10175% Vol realized risk). By comparison, AAL carries 63.2% implied volatility (22nd %ile, Compressed (<25th %ile)), a 1.70x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (1.82β · 55% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.